NCT00896857
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
- Locations
-
Not specified
Clinical trial condition
Neoplasms, Ductal, Lobular, and Medullary
Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.
487 public trials
100 recruiting studies
Neoplasms, Ductal, Lobular, and Medullary trial results
NCT00182793
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +14 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
NCT01060085
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +13 more
- Locations
-
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
NCT00118248
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +22 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00358956
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +17 more
- Locations
-
- Research Site Little Rock, Arkansas, United States
- Research Site Boston, Massachusetts, United States
- Research Site St Leonards, Australia
- Research Site Sherbrooke, Quebec, Canada
NCT02199418
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
- Shanghai Jiaotong University School of Medicine, Renji Hospital Shanghai, Shanghai Municipality, China
NCT00005886
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
- Comprehensive Cancer Centers of the Desert Palm Springs, California, United States
- Loyola University Medical Center Maywood, Illinois, United States
NCT00637481
- Conditions
- Adenocarcinoma, Atypical Ductal Breast Hyperplasia, Breast Cancer, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial
NCT01372644
- Conditions
- Adenocarcinoma, Atypical Ductal Breast Hyperplasia, Atypical Lobular Hyperplasia (ALH) of Breast, +14 more
- Locations
-
- NYU School of Medicine New York, United States
NCT01661179
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +14 more
- Locations
-
- Research Site Fukuoka, Japan
- Research Site Kobe, Japan
- Research Site Kōtoku, Japan
- Research Site Shinjuku-ku, Japan